908 Devices Inc. (MASS) Stock Score, Valuation & Financial Research
908 Devices Inc. is in the Healthcare sector and Medical - Specialties industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 31/100.
Quick answer for MASS
908 Devices Inc. currently has a Wall Street Score of 31/100. The stored market price is $9.97. Its financial score is 50/100. Its valuation score is 43/100. These figures are a research snapshot, not a buy or sell recommendation.
What 908 Devices Inc. does
908 Devices Inc. provides purpose-built handheld mass spectrometry and fourier transform infrared (FTIR) devices for use in vital health and safety applications. The company’s products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; XplorIR, a handheld device that uses FTIR spectroscopy to identify, quantify, and track gases and vapors; ThreatID, a portable FTIR device that rapidly detects and identifies approximately 28,000 unknown gas, vapor, powder, and liquid chemical hazards; ProtectIR, a handheld FTIR device that can identify approximately 23,000 solid and liquid chemical hazards; and VipIR, a handheld 3-in-1 analyzer that integrates FTIR, Raman spectroscopy, and smart spectral processing (SSP), a proprietary algorithm, to provide a single result from just one sa
MASS financial snapshot
- Wall Street Score:
- 31/100
- Current price:
- $9.97
- Market capitalization:
- $409.0M
- Revenue:
- $57.8M
- Net income:
- $-35.9M
- Free cash flow:
- $-24.6M
- Cash:
- $67.6M
- Total debt:
- $4.5M
- EPS:
- 0.54
- P/E ratio:
- 18.5x
- Financial score:
- 50/100
- Valuation score:
- 43/100
- Revenue score:
- 10/100
What stands out
- Reported year-over-year revenue growth is +0.0%.
- Free cash flow is $-24.6M, showing cash burn in the current stored period.
- The balance sheet shows $67.6M of cash versus $4.5M of total debt, leaving more cash than debt.
What the numbers mean
Its current valuation score is 43/100, which Wall Street Score classifies as weak within the model's valuation framework.
The financial score is 50/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-07-24.
How to research MASS
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.